Home Blood Pressure Monitoring in Kidney Transplant Recipients

Inclusion Criteria: 1. Kidney transplant recipient 2. Male or female subject ≥ 18 years old 3. Any or more of the following at the baseline clinic * Conventional office BP ≥130 mmHg systolic and/or ≥ 80 mmHg diastolic * HBPM ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months (see appendix 1 for details on methodology) * Daytime ambulatory blood pressure monitoring (ABPM) ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months 4. Signed informed consent and expected cooperation of the patient for the treatment and follow up. 5. Have a national personal identification number and not be expected to emigrate during study 6. Enlisted in the Norwegian Renal Registry Exclusion Criteria: 1. Standing systolic BP \< 110 mmHg (to avoid adverse events). Measured after one and three minutes of standing. Not applicable if unable to stand due to wheelchair use. 2. Diagnosed atrial fibrillation (automated monitors not validated) 3. Unwilling to self-monitor 4. Female participant who is pregnant, lactating or planning pregnancy during the trial (management of essential hypertension in pregnancy is different) 5. Arm circumference too large or small to allow accurate BP measurement with available device (22-42 cm). 6. Any reason likely limiting adherence to interventions, as judged by the investigator; examples include active alcohol or substance abuse within the last 12 months, significant poor compliance with medications or attendance at clinic visits, residence in a nursing home, dementia, other medical or psychiatric conditions that may interfere with study participation. 7. Graft- or life expectancy less than 2 years, as judged by the investigator. 8. Current use of ≥ 4 antihypertensive medications 9. More than half of regular appointments planned as remote (e.g. phone or video) consultations. 10. Severe white-coat hypertension, e.g. patients already treated solely based on home BP values. 11. Multi-organ transplants (e.g. heart, lung, liver), though pancreas or beta-cell islet transplant is allowed.